Post by Roche Diagnostics USA

With cervical-cancer screening intervals safely extending to five years, the initial baseline test carries an immense responsibility. Complete HPV DNA detection is essential to provide diagnostic certainty to patients and clinicians. Denise Heaney, Ph.D., highlights how highly accurate DNA testing as a first step ensures no critical risk factor is left unseen. Discover how we’re supporting clinicians and laboratories to deliver long-term patient safety:https://lnkd.in/dbayNPQs